PETER HUDSPETH is a highly experienced
healthcare professional with a proven track
record of success spanning more than 30 years
on both client and agency sides of the business.
He has gained a reputation for being
strategically focused, having excellent
organisational and planning skills, and
delivering the highest levels of service to clients.
Peter has launched and/or managed many major human and animal healthcare brands, including: Aggrastat, Aricept, Canesten, Capoten, Clexane/Lovenox, Cozaar, Dectomax, Eprinex, Eqvalan, Ivomec, Keppra, Mepact, Nicorette, Omacor, Optimmune, Oramec, Pariet, Reyataz, SMA, Symbicort, Toviaz and Xyzal.
He has previously held agency management positions at Dratfcb Healthcare (Interpublic Group), LEC\TBWA\WorldHealth (Omnicom Group) and Euro RSCG Healthcare (Havas).
JEFF DANIELS began his career in FMCG
brand development before specialising in OTC
and Rx healthcare.
He has contributed to the success of many
of the world's leading brands in addition to a
number of specialty/niche brands and has
been awarded more than 40 international
creative awards and commendations.
Jeff's experience covers almost all therapeutic categories,
and major brands he has helped launch, or relaunch, include: Atripla, Crestor, Imigran, Innovace, Keppra, Mepact,
Mirena, NeoClarityn, Plavix, Reyataz, Singulair, Spiriva, Sustiva, Toviaz, Tritace, Vesicare, Viagra, Xyzal, and Zantac.
He has previously held creative director positions at Draftfcb Healthcare (Interpublic Group), LEC\TBWA\WorldHealth (Omnicom Group) and Grey Healthcare Group (WPP).
Mobile: +44 (0)7748 184 119
Office: +44 (0)20 7887 6046
© Copyright 2016 Daniels Hudspeth Ltd. All Rights Reserved.